Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders such as suicidal depression, bipolar disorder, PTSD, and chronic pain. Its key products include NMDA receptor modulators like NRX-100 and NRX-101, targeting rapid relief of suicidality and depression. The company also operates HOPE Therapeutics, a care delivery platform with clinics treating psychiatric conditions, integrating innovative drug development with patient care.
This description was generated via AI from an annual report. Updated about 1 year ago.